These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22839360)

  • 21. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Seymour JF
    Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-GM-CSF autoantibodies (GM-CSF autoantibodies)].
    Watanabe M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():684-6. PubMed ID: 20942163
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF.
    Krinner EM; Raum T; Petsch S; Bruckmaier S; Schuster I; Petersen L; Cierpka R; Abebe D; Mølhøj M; Wolf A; Sørensen P; Locher M; Baeuerle PA; Hepp J
    Mol Immunol; 2007 Feb; 44(5):916-25. PubMed ID: 16697465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.
    Ataya A; Knight V; Carey BC; Lee E; Tarling EJ; Wang T
    Front Immunol; 2021; 12():752856. PubMed ID: 34880857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM-CSF autoantibodies in pulmonary alveolar proteinosis.
    Bendtzen K; Svenson M; Hansen MB
    N Engl J Med; 2007 May; 356(19):2001; author reply 2002. PubMed ID: 17494938
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.
    Piccoli L; Campo I; Fregni CS; Rodriguez BM; Minola A; Sallusto F; Luisetti M; Corti D; Lanzavecchia A
    Nat Commun; 2015 Jun; 6():7375. PubMed ID: 26077231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Carey B; Chalk C; Suzuki T; Sakagami T; Koch DE; Stevens C; Inoue Y; Yamada Y; Trapnell BC
    J Immunol Methods; 2014 Jan; 402(1-2):57-70. PubMed ID: 24275678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement.
    Lo YF; Wang SY; Wu YH; Ho MW; Yeh CF; Wu TY; Peng JJ; Lin YN; Ding JY; Shih HP; Lo CC; Chan YP; Rau CS; Kuo CY; Tu KH; Lei WT; Chen YC; Ku CL
    J Clin Immunol; 2024 Aug; 44(8):176. PubMed ID: 39133333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM-CSF pathway correction in pulmonary alveolar proteinosis.
    Antoniu SA
    Expert Opin Biol Ther; 2010 Sep; 10(9):1357-65. PubMed ID: 20695835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticytokine autoantibodies in infection and inflammation: an update.
    Barcenas-Morales G; Jandus P; Döffinger R
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):523-529. PubMed ID: 27755185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulmonary alveolar proteinosis: role of GM-CSF Antibodies].
    Ernst G; Salvado A; Grynblat P; Tabaj G; Garcia O; Cambursano VH; Young P
    Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(1):46-50. PubMed ID: 28379131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
    Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.
    Bonfield TL; John N; Barna BP; Kavuru MS; Thomassen MJ; Yen-Lieberman B
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):821-4. PubMed ID: 16002629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does dust-associated pulmonary alveolar proteinosis represent an autoimmune disorder?
    Uzmezoglu B; Simsek C; Gulgosteren S; Gebesoglu BE
    Am J Ind Med; 2017 Jun; 60(6):591-597. PubMed ID: 28514019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.
    Steidl S; Ratsch O; Brocks B; Dürr M; Thomassen-Wolf E
    Mol Immunol; 2008 Nov; 46(1):135-44. PubMed ID: 18722015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.